Seven ways to preserve the Miracle of antibiotics

John G. Bartlett; David N. Gilbert; Brad Spellberg

doi:10.1093/cid/cit070

Seven ways to preserve the Miracle of antibiotics

John G. Bartlett, David N. Gilbert, Brad Spellberg

School of Medicine

Research output: Contribution to journal › Review article › peer-review

199 Scopus citations

Abstract

Antibiotic resistance is a well-acknowledged crisis with no clearly defined comprehensive, national corrective plan. We propose a number of interventions that, collectively, could make a large difference. These include collection of data to inform decisions, efforts to reduce antibiotic abuse in people and animals, great emphasis on antibiotic stewardship, performance incentives, optimal use of newer diagnostics, better support for clinical and basic resistance-related research, and novel methods to foster new antibiotic development.

Original language	English (US)
Pages (from-to)	1445-1450
Number of pages	6
Journal	Clinical Infectious Diseases
Volume	56
Issue number	10
DOIs	https://doi.org/10.1093/cid/cit070
State	Published - May 15 2013

Keywords

European Union, stewardship
antibiotic resistance
antibiotic salvage
molecular diagnostics

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1093/cid/cit070

Cite this

@article{1a7e42b9932846eba50b95a94a62d043,

title = "Seven ways to preserve the Miracle of antibiotics",

abstract = "Antibiotic resistance is a well-acknowledged crisis with no clearly defined comprehensive, national corrective plan. We propose a number of interventions that, collectively, could make a large difference. These include collection of data to inform decisions, efforts to reduce antibiotic abuse in people and animals, great emphasis on antibiotic stewardship, performance incentives, optimal use of newer diagnostics, better support for clinical and basic resistance-related research, and novel methods to foster new antibiotic development.",

keywords = "European Union, stewardship, antibiotic resistance, antibiotic salvage, molecular diagnostics",

author = "Bartlett, {John G.} and Gilbert, {David N.} and Brad Spellberg",

note = "Funding Information: Potential conflicts of interest. J. G. B. has received payment for consultation or honoraria from Epocrates, Medscape, and Medicine. B. S. has received institutional grant support from Cubist, Pfizer, Eisai, and Bristol-Myers Squibb, and has received payment for consultation or honoraria from GlaxoSmithKline, Pfizer, Basilea, The Medicines Company, Achao-gen, Eisai, Meiji, Polymedix, Cardeas, Affinium, and Adenium. D. G. reports no potential conflicts.",

year = "2013",

month = may,

day = "15",

doi = "10.1093/cid/cit070",

language = "English (US)",

volume = "56",

pages = "1445--1450",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "10",

}

TY - JOUR

T1 - Seven ways to preserve the Miracle of antibiotics

AU - Bartlett, John G.

AU - Gilbert, David N.

AU - Spellberg, Brad

N1 - Funding Information: Potential conflicts of interest. J. G. B. has received payment for consultation or honoraria from Epocrates, Medscape, and Medicine. B. S. has received institutional grant support from Cubist, Pfizer, Eisai, and Bristol-Myers Squibb, and has received payment for consultation or honoraria from GlaxoSmithKline, Pfizer, Basilea, The Medicines Company, Achao-gen, Eisai, Meiji, Polymedix, Cardeas, Affinium, and Adenium. D. G. reports no potential conflicts.

PY - 2013/5/15

Y1 - 2013/5/15

N2 - Antibiotic resistance is a well-acknowledged crisis with no clearly defined comprehensive, national corrective plan. We propose a number of interventions that, collectively, could make a large difference. These include collection of data to inform decisions, efforts to reduce antibiotic abuse in people and animals, great emphasis on antibiotic stewardship, performance incentives, optimal use of newer diagnostics, better support for clinical and basic resistance-related research, and novel methods to foster new antibiotic development.

AB - Antibiotic resistance is a well-acknowledged crisis with no clearly defined comprehensive, national corrective plan. We propose a number of interventions that, collectively, could make a large difference. These include collection of data to inform decisions, efforts to reduce antibiotic abuse in people and animals, great emphasis on antibiotic stewardship, performance incentives, optimal use of newer diagnostics, better support for clinical and basic resistance-related research, and novel methods to foster new antibiotic development.

KW - European Union, stewardship

KW - antibiotic resistance

KW - antibiotic salvage

KW - molecular diagnostics

UR - http://www.scopus.com/inward/record.url?scp=84877294743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877294743&partnerID=8YFLogxK

U2 - 10.1093/cid/cit070

DO - 10.1093/cid/cit070

M3 - Review article

C2 - 23403172

AN - SCOPUS:84877294743

SN - 1058-4838

VL - 56

SP - 1445

EP - 1450

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 10

ER -

Seven ways to preserve the Miracle of antibiotics

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this